Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

FDA issues marketing denial for 6,500 flavored e-cigarettes

Published 05/12/2023, 02:34 PM
Updated 05/12/2023, 07:21 PM
© Reuters. FILE PHOTO: Flavored e-cigarette products are seen on a store shelf in Raleigh, North Carolina, U.S., June 23, 2022.  REUTERS/Arriana Mclymore

(Reuters) -The U.S. Food and Drug Administration (FDA) on Friday issued marketing denial orders to 10 companies which collectively manufacture and market about 6,500 flavored e-liquid and e-cigarette products.

The health regulator said these companies cannot market or distribute the products in the U.S. and retailers who sell them risk FDA enforcement action.

Any company that wants to legally market a new tobacco product in the United States must receive a written marketing order from FDA. But if the health regulator deems it unfit for public health, it issues a marketing denial order.

The FDA named eight of these companies that received the denial orders, which include Imperial Vapors LLC, Savage Enterprises and Big Time Vapes, among others.

However, the FDA said it was not disclosing the names of the other two companies to protect potential confidential commercial information.

The FDA added the premarket tobacco product applications (PMTAs) submitted for a variety of flavored e-cigarette products did not provide sufficient evidence to show that permitting the marketing of these products would be appropriate for public health.

Some of the flavors denied by the health regulator include Citrus, Strawberry Cheesecake, Cool Mint and Menthol.

© Reuters. FILE PHOTO: Flavored e-cigarette products are seen on a store shelf in Raleigh, North Carolina, U.S., June 23, 2022.  REUTERS/Arriana Mclymore

However, Altria Group (NYSE:MO) Inc's NJOY has six e-cigarette products which have received full approval from the FDA.

Juul, another e-cigarette maker in which Altria was a former investor, is still seeking approval for its products. The FDA last year briefly banned Juul's products but put it on hold and agreed to reconsider after the company appealed.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.